J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 310 pp 1-11
Copyright © 1981 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Partlow, L M
Right arrow Articles by Wardell, L J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Partlow, L M
Right arrow Articles by Wardell, L J

Nerve growth factor and an anticomplimentary protease in mouse saliva elicited by nerve stimulation.

L M Partlow, L J Wallace and L J Wardell

1. Three substances previously identified in mouse saliva ((1) biologically active nerve growth factor (NGF), (2) a material immunologically identical to the alpha-subunit of 7S-NGF and (3) an anticomplementary protease) were quantified in both mandibular gland saliva and mixed salivary secretions elicited by stimulation of either the sympathetic or parasympathetic nerves to the salivary glands. 2. The concentrations and specific activities of all three substances in pure mandibular saliva equalled or exceeded those found in mixed secretions from all salivary glands. 3. All three substances were found to be primarily secreted as a result of sympathetic rather than parasympathetic nerve stimulation as their concentrations and specific activities were much greater in sympathetic than in parasympathetic mixed salivary secretions. 4. Bioactive NGF, alpha-subunit-like material, and an anticomplementary protease were demonstrated to be released selectively through activation of alpha-adrenergic receptors as the concentrations and specific activities of all three substances were markedly reduced by pre-treatment with an alpha-adrenergic blocker (phenoxybenzamine) but not by pre-treatment with either a muscarinic or a beta-adrenergic blocker (atropine or propranolol, respectively). 5. Measurement of total protein in saliva elicited by sympathetic nerve stimulation following pre-treatment with an alpha-adrenergic, beta-adrenergic, or muscarinic blocking agent demonstrated that proteins other than those examined in the present study must be released by activation of beta-adrenergic receptors.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 The Physiological Society.